Evidence map›Paper›PMID 33681463›Full record

ArticleTomography (Ann Arbor, Mich.)2021

Identifying Robust Radiomics Features for Lung Cancer by Using In-Vivo and Phantom Lung Lesions.

Lin Lu, Shawn H Sun, Aaron Afran, Hao Yang, Zheng Feng Lu, James So, Lawrence H Schwartz, Binsheng Zhao

Abstract read
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Delta radiomics: a systematic review.La Radiologia medica · 2021
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lin LuDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA.
Shawn H SunDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA.ORCID 0000-0002-6170-1949
Aaron AfranDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA.
Hao YangDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA.
Zheng Feng LuDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA.
James SoDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA.
Lawrence H SchwartzDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA.
Binsheng ZhaoDepartment of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA.

Funding

Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung CancerU01CA225431 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SCHWARTZ, LAWRENCE H, ZHAO, BINSHENG · 2018 to 2022
$3.1M
Studying measurement variability in tumor volume and volume change on MDCTR01CA149490 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHAO, BINSHENG · 2011 to 2016
$1.7M
NCI NIH HHS R01 CA149490NCI NIH HHS U01 CA225431
6 · The paper itself

Abstract

We propose a novel framework for determining radiomics feature robustness by considering the effects of both biological and noise signals. This framework is preliminarily tested in a study predicting the epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC) patients. Pairs of CT images (baseline, 3-week post therapy) of 46 NSCLC patients with known EGFR mutation status were collected and a FDA-customized anthropomorphic thoracic phantom was scanned on two vendors' scanners at four different tube currents. Delta radiomics features were extracted from the NSCLC patient CTs and reproducible, non-redundant, and informative features were identified. The feature value differences between EGFR mutant and EGFR wildtype patients were quantitatively measured as the biological signal. Similarly, radiomics features were extracted from the phantom CTs. A pairwise comparison between settings resulted in a feature value difference that was quantitatively measured as the noise signal. Biological signals were compared to noise signals at each setting to determine if the distributions were significantly different by two-sample

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansLungPhantoms, ImagingEGFRNSCLCphantomradiomicsreproducibilityrobustness

Identifiers

PMID33681463
PMCPMC7934702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.